Two Labs announced it has acquired MKO Global Partners, a strategic global life sciences consulting firm focused on payer strategy, market access, and pricing in the pharmaceutical and biotech markets.
Two Labs' mission is to improve patients' quality of life by delivering innovative trade and commercialization services to pharmaceutical manufacturers. The MKO acquisition enhances this mission by integrating new capabilities in pricing and market access strategy. The transaction combines two performance-driven organizations that share a commitment to innovation, collaboration and client service.
"The pharmaceutical industry relies on Two Labs to provide commercialization support services so that they can focus on developing new and innovative therapies that enhance patients' lives. The union of Two Labs' and MKO's pharma services expands our total solution suite through the addition of a highly-regarded market access solutions provider," said Rich Wartel, CEO of Two Labs. Wartel continued, "For both organizations, culture matters as much as our solutions. As a result, our clients view us as a strategic partner and an extended part of their team—not as a vendor."
The transaction was completed as of February 2, 2018. Terms of the agreement were not disclosed.